کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
877352 | 911018 | 2016 | 8 صفحه PDF | دانلود رایگان |
To prevent percutaneous device associated infections (PDAIs), we prepared electrospun chitosan/poly(ethylene oxide) (PEO) nanofibrous membrane containing silver nanoparticles as an implantable delivery vehicle for the dual release of chlorhexidine and silver ions. We observed that the silver nanoparticles were distributed homogeneously throughout the fibers, and a fast release of chlorhexidine in 2 days and a sustained release of silver ions for up to 28 days. The antibacterial efficacy of the membranes against Staphylococcus aureus showed that the membranes exhibited an obvious inhibition zone upon loading with either chlorhexidine (20 μg or more per membrane) or AgNO3 (1 and 5 wt% to polymer). Furthermore, long-term antibacterial effect up to 4 days was verified using membranes containing 5 wt% AgNO3. The results suggest that the membranes have strong potential to act as an active antibacterial dressing for local delivery of antibacterial agents to prevent PDAIs.
Graphical AbstractWe prepared electrospun chitosan nanofibrous membranes containing homogeneous distributed silver nanoparticles (TEM images) and chlorhexidine (CHX) to prevent percutaneous device associated infections. We observed sustained release of silver ions from the nanofibrous membranes for more than 28 days (release image). These membranes had obvious antibacterial effects against Staphylococcus aureus (antibacterial test images).Figure optionsDownload high-quality image (538 K)Download as PowerPoint slide
Journal: Nanomedicine: Nanotechnology, Biology and Medicine - Volume 12, Issue 5, July 2016, Pages 1357–1364